News | 15 January 2013
15, 2013 /PRNewswire/ -- Velocity Pharmaceutical Development LLC (VPD) today announced the signing of a Licensing Agreement to pursue a drug development program utilizing EuMederis Pharmaceuticals' EuPort ? technology for optimizing the ...
Click on the link to read the full article at PharmaLive (press release) (subscription)
(This link will open in a new window)